** Shares of veterinary services provider CVS Group Plc CVSG.L rise 3.31% to 1,248p
** Peel Hunt upgrades stock to "buy" from "add", citing clearer signs of a positive outcome from the Competition and Markets Authority and progress in Australia
** Raises price target to 1,600p from 1,500p; a 32.4% upside to the stock's last close on Monday
** "The company has made strong progress in Australia, which now contributes 10% of EBITDA. There is considerable potential given CVS’ small market share, healthy margins, and potential synergies," brokerage adds
** Peel Hunt also says the CMA investigation is slowly nearing its end after a long delay, and based on recent updates, the outcome is expected to be mild and not harmful to the industry
** Stock rated "buy" from an average of nine analysts' ratings; median PT is 1,500p, per data compiled by LSEG
** As of last close, the stock is up ~48% this year
(Reporting by Akriti Shah in Bengaluru)
((akriti.shah@thomsonreuters.com))